Market Research Logo

Global Structural Heart Disease Treatment Devices Market 2018-2022

Global Structural Heart Disease Treatment Devices Market 2018-2022

About Structural Heart Disease Treatment Devices

Global structural heart disease treatment devices are repair and replacement devices used for the treatment of structural heart diseases that could lead to a heart attack, or any other issue occurring in the valves or vessels of the heart.

Technavio’s analysts forecast the Global Structural Heart Disease Treatment Devices Market to grow at a CAGR of 9.5% during the period 2018-2022.

Covered in this report

The report covers the present scenario and the growth prospects of the Global Structural Heart Disease Treatment Devices Market. To calculate the market size, the report considers the revenue generated from the sales of structural heart disease treatment devices.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Structural Heart Disease Treatment Devices Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Abbott
  • Boston Scientific
  • Edwards Lifesciences
  • LivaNova
  • Lepu Medical Technology
  • Medtronic
Market driver
  • Increase in technological advancements/improvements
  • For a full, detailed list, view our report
Market challenge
  • Increase in product recalls
  • For a full, detailed list, view our report
Market trend
  • Emergence of MRI conditional heart valves
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – Global Structural Heart Disease Treatment Devices Market 2018-2022

Technavio recognizes the following companies as the key players in the Global Structural Heart Disease Treatment Devices Market: Abbott, Boston Scientific, Edwards Lifesciences, LivaNova, Lepu Medical Technology, Medtronic

Commenting on the report, an analyst from Technavio’s team said: “One trend affecting this market is the increase in product launches coupled with R&D activities. Vendors are strategically focusing on the development and commercial launch of their devices for treating a broad range of structural heart diseases.”

According to the report, one driver influencing this market is the growing prevalence of heart-related disorders. Various cardio-related disorders including stroke, congenital heart disease, peripheral arterial disease and others require surgical intervention to repair or replace damaged valves and treat damaged or defective areas in the heart.

Further, the report states that one of the factors affecting this market is the risks and complications associated with structural heart implants. Replacement of heart valves at old age is associated with a high probability of mortality. Risks and potential complications associated with the devices used in repair or replacement procedures may hinder the growth prospects of the market.

Companies Mentioned

Abbott

Boston Scientific

Edwards Lifesciences

LivaNova

Lepu Medical Technology

Medtronic

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
Market ecosystem
Market characteristics
Market segmentation analysis
PART 05: MARKET SIZING
Market definition
Market sizing 2017
Market size and forecast 2017-2022
PART 06: FIVE FORCES ANALYSIS
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition
PART 07: MARKET SEGMENTATION BY PRODUCT
Segmentation by product
Comparison by product
Repair devices – Market size and forecast 2017-2022
Replacement devices – Market size and forecast 2017-2022
Market opportunity by product
PART 08: CUSTOMER LANDSCAPE
PART 09: REGIONAL LANDSCAPE
Geographical segmentation
Regional comparison
Americas – Market size and forecast 2017-2022
EMEA – Market size and forecast 2017-2022
APAC – Market size and forecast 2017-2022
Market opportunity
PART 10: DECISION FRAMEWORK
PART 11: DRIVERS AND CHALLENGES
Market drivers
Market challenges
PART 12: MARKET TRENDS
Increase in product launches coupled with R&D activities
Growing popularity of sutureless aortic valve replacement devices
Increase in strategic M&A
Emergence of MRI conditional heart valves
PART 13: VENDOR LANDSCAPE
Overview
Landscape disruption
PART 14: VENDOR ANALYSIS
Vendors covered
Vendor classification
Market positioning of vendors
Abbott
Boston Scientific
Edwards Lifesciences
LivaNova
Lepu Medical Technology
Medtronic
PART 15: APPENDIX
List of abbreviations
Exhibit 01: Parent market
Exhibit 02: Global cardiovascular devices market
Exhibit 03: Market characteristics
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2017
Exhibit 07: Validation techniques employed for market sizing 2017
Exhibit 08: Global structural heart disease treatment devices market – Market size and forecast 2017-2022 ($ mn)
Exhibit 09: Global structural heart disease treatment devices market – Year-over-year growth 2018-2022 (%)
Exhibit 10: Five forces analysis 2017
Exhibit 11: Five forces analysis 2022
Exhibit 12: Bargaining power of buyers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition - Five forces 2017
Exhibit 17: Product – Market share 2017-2022 (%)
Exhibit 18: Comparison by product
Exhibit 19: Repair devices – Market size and forecast 2017-2022 ($ mn)
Exhibit 20: Repair devices – Year-over-year growth 2018-2022 (%)
Exhibit 21: Replacement devices – Market size and forecast 2017-2022 ($ mn)
Exhibit 22: Replacement devices – Year-over-year growth 2018-2022 (%)
Exhibit 23: Market opportunity by product
Exhibit 24: Customer landscape
Exhibit 25: Global – Market share by geography 2017-2022 (%)
Exhibit 26: Regional comparison
Exhibit 27: Americas – Market size and forecast 2017-2022 ($ mn)
Exhibit 28: Americas – Year-over-year growth 2018-2022 (%)
Exhibit 29: Top 3 countries in Americas
Exhibit 30: EMEA – Market size and forecast 2017-2022 ($ mn)
Exhibit 31: EMEA – Year-over-year growth 2018-2022 (%)
Exhibit 32: Top 3 countries in EMEA
Exhibit 33: APAC – Market size and forecast 2017-2022 ($ mn)
Exhibit 34: APAC – Year-over-year growth 2018-2022 (%)
Exhibit 35: Top 3 countries in APAC
Exhibit 36: Market opportunity
Exhibit 37: Product recalls in structural heart disease treatment devices market 2015-2017
Exhibit 38: New product launches in 2016 – 2017
Exhibit 39: Major M&A deals during 2015–2017
Exhibit 40: Vendor landscape
Exhibit 41: Landscape disruption
Exhibit 42: Vendors covered
Exhibit 43: Vendor classification
Exhibit 44: Market positioning of vendors
Exhibit 45: Abbott overview
Exhibit 46: Abbott – Business segments
Exhibit 47: Abbott – Organizational developments
Exhibit 48: Abbott – Geographic focus
Exhibit 49: Abbott – Segment focus
Exhibit 50: Abbott – Key offerings
Exhibit 51: Abbott – Key customers
Exhibit 52: Boston Scientific overview
Exhibit 53: Boston Scientific – Product categories
Exhibit 54: Boston Scientific – Organizational developments
Exhibit 55: Boston Scientific – Geographic focus
Exhibit 56: Boston Scientific – Segment focus
Exhibit 57: Boston Scientific – Key offerings
Exhibit 58: Boston Scientific – Key customers
Exhibit 59: Edwards Lifesciences overview
Exhibit 60: Edwards Lifesciences – Business segments
Exhibit 61: Edwards Lifesciences – Organizational developments
Exhibit 62: Edwards Lifesciences – Geographic focus
Exhibit 63: Edwards Lifesciences – Segment focus
Exhibit 64: Edwards Lifesciences – Key offerings
Exhibit 65: Edwards Lifesciences – Key customers
Exhibit 66: LivaNova overview
Exhibit 67: LivaNova – Business segments
Exhibit 68: LivaNova – Organizational developments
Exhibit 69: LivaNova – Geographic focus
Exhibit 70: LivaNova – Segment focus
Exhibit 71: LivaNova – Key offerings
Exhibit 72: LivaNova – Key customers
Exhibit 73: Lepu Medical Technology overview
Exhibit 74: Lepu Medical Technology – Products categories
Exhibit 75: Lepu Medical Technology – Organizational developments
Exhibit 76: Lepu Medical Technology – Geographic focus
Exhibit 77: Lepu Medical Technology – Segment focus
Exhibit 78: Lepu Medical Technology – Key offerings
Exhibit 79: Lepu Medical Technology – Key customers
Exhibit 80: Medtronic: Overview
Exhibit 81: Medtronic: Product categories
Exhibit 82: Medtronic: Organizational developments
Exhibit 83: Medtronic: Geographic focus
Exhibit 84: Medtronic: Segment focus
Exhibit 85: Medtronic: Key offerings
Exhibit 86: Medtronic: Key customers

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report